1Kraus LA, Samuel SK, Schmid SM, et al. The mechanism of action of docetaxel (Taxotere) in xenograft models is not limitod to BCI -2-2 phosphorylation. Invest New Drugs ,2003,21:259-268.
3SUNOM, ONO T, IIDA S, et al. Improved high performance liquid chromatographic detection of paclitaxel in patient' s plasma using solid-phase extraction, and semi-micro-bore C18 separation and UV detection. J Chromatogr: B ,2007,860 ( 1 ) :141-144.
1Ki KD, Song DH, Tong SY, et al. Neoadjuvant chemotherapy in bulky stage IB - IIA cervical cancer: results of a quick course with vincristine, bleomycin,and cisplatin[ J~. Int J Gynecol Cancer, 2009,19 ( 1 ) : 50 - 53 . PMID : 19258941.
2Manci N, Marchetti C, Di Tucci C, et al. A prospective phase II study of topotecan (Hyeamtin?) and cisplatin as neoadjuvant chemotherapy inlocallyadvanced cervical cancer [ J ]. Gynecol Oncol, 2011,122 ( 2 ) 285 - 29O.
3McCormack M, Kadalayil L, Hackshaw A, et al. A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer[ J~. Br J Cancer, 2013,108 (12) :2664 - 2469.
4Lorusso D, Ramondino S, Mancini M, et al. Phase II trial on cisplatin - adriamycin - paclitaxel combination as neoadjuvant chemotherapy for lo- cally advancedcervical adenocarcinoma [ J ]. Int J Gynecol Cancer, 2014,24 (4) :729 - 734.
5Kuo DY, Blank SV, Christos PJ, et al. Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study[ J~. Gynecol Oncol, 2010,116 ( 3 ) :442 - 446.
